Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).
Zydus is the first company to receive final approval and launch Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg in the United States.
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, (RLD Toviaz®) had estimated annual sales of USD 177 million in the U.S. (IQVIA MAT September 2022).
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
All claims against the company in the litigation have now been dismissed.
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
Subscribe To Our Newsletter & Stay Updated
